Kodiak Sciences Inc. ↗
Biotechnology: Biological Products (No Diagnostic Substances) company
Key Metrics of Kodiak Sciences Inc.
Revenue—FY 2023
Operating income−$277M▲ 18.8% YoY
Net profit−$260M▲ 22.0% YoY
Shareholders' equity$266M
Market cap$5.6BKOD · $89.60
About Kodiak Sciences Inc.
Company details
- Website
- kodiak.com
- Founded
- 2018
- Listed
- Nasdaq: KOD (since 2018)
Company summary
Legal nameKodiak Sciences Inc
TickerKOD
ExchangeNasdaq
CountryUnited States
SEC CIK0001468748
Listed since2018
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
SectorOther Industries · Discovered Companies
Websitehttps://kodiak.com
US market & SEC filings
KOD · Nasdaq · SEC CIK 0001468748
Last price · 28 Oct 2026
$89.60
+2.25%
Market cap$5.6B
P/E—On FY 2023 diluted EPS
Volume927,147
SectorHealth CareBiotechnology: Biological Products (No Diagnostic Substances)
Country · IPOUnited StatesListed 2018
KOD share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered officePalo Alto
GSTIN—
Email—
Websitehttps://kodiak.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.
Filings
No filings on record yet.